MedTrace Logo

Improving Diabetes Outcomes for People With Severe Mental Illness (SMI)

NCT03534921 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 46564

Last updated 2020-03-24

No results posted yet for this study

Summary

This study aims to identify the determinants of diabetes and to explore variation in diabetes outcomes for people with severe mental illness (schizophrenia, schizoaffective disorder and bipolar disorder) in order to develop potential healthcare interventions that can be tested further.

The study utilises a mixed methods design comprising analysis of patient primary care records and interviews with patients living with comorbid SMI and diabetes, family carers and healthcare professionals involved in commissioning or delivering healthcare for this population. This entry on the Protocol Registration and Results System describes only the quantitative Work Package of the study in detail i.e. analysis of patient primary care records.

Conditions

  • Diabetes Mellitus, Type 2
  • Severe Mental Disorder

Sponsors & Collaborators

  • University of Leeds

    collaborator OTHER

  • University of Southampton

    collaborator OTHER

  • University of York

    lead OTHER

Principal Investigators

  • Dr Siddiqi · University of York

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2019-10-31
Completion
2019-10-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03534921 on ClinicalTrials.gov